Greenwich Lifesciences Inc (GLSI)
US$ 14.394.2%
Price Chart
Key Statistics
Market Cap
$ 134.08M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
18.81K
52W High
$ 17.19
52W Low
$ 8.06
Dividend Yield
0.00%
Beta
3.25
Technicals
50-Day MA
9.5948
200-Day MA
11.8195
52 Week High
17.1882
52 Week Low
8.06
About GLSI
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.
Employees
4
Headquarters
Stafford, TX
CEO
Mr. Snehal S. Patel
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg